Form 4: Astrana Health Director Thomas S. Lam Reports Stock Grants and Holdings

Director Thomas S. Lam reports acquisition of restricted stock grants and adjustments to beneficial ownership in Astrana Health, Inc.

Summary

• Thomas S. Lam, a director of Astrana Health, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• The report indicates the acquisition of 13,333 restricted shares and 26,667 restricted shares of common stock on November 8, 2024, both granted under the Issuer's 2024 Equity Incentive Plan.
• These shares are subject to vesting schedules dependent on continued employment and, in the case of 26,667 shares, the achievement of pre-established performance goals.
• Lam's direct holdings following the transactions amount to 438,855 shares.
• He also indirectly owns 1,107,474 shares through the Thomas and Jeanette Lam 2002 Family Trust and 7,132,698 shares through Allied Physicians of California, a Professional Medical Corporation.
• Lam disclaims beneficial ownership of the shares held by Allied Physicians of California except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a standard regulatory filing. The stock grants could be seen as a positive sign of aligning management interests with shareholders, but it's not a major event.

Positives

• The grant of restricted stock to a director aligns their interests with those of the shareholders.
• The vesting requirements based on continued employment and performance goals may incentivize the director to contribute to the company's success.

Future Outlook

The vesting of the restricted stock is contingent upon continued employment and, for some shares, the achievement of pre-established performance goals, suggesting a focus on long-term performance and retention.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The stock grants align the director's interests with shareholders, potentially leading to decisions that benefit the company's long-term value.
• Employees may be motivated by the performance-based vesting of some of the shares.

Key Dates